KLF4 and colorectal carcinoma: Other chemicals are used to modulate KLF expression: 5,5’-DibromoDIM up-regulates expression of KLF4 in CRC-derived cell lines, and may represent a novel class of mechanism-based therapeutic drug for CRC [9].